Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Tosilate for Local Anesthesia Assisted Sedation
NCT05015361Phase 2Completed
- Sponsor
- Hengrui
- Start
- May 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of remimazolam in Procedural sedation (PS) (2 arms), sponsored by Hengrui. Primary endpoint: The time to maintain target sedation as a percentage of the total study administration time at 1 hour. Started May 2021; status: completed.
02
Drugs
remimazolam
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT05015361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05015361.